Cell X is revolutionizing cell processing. At the core of this revolution lies our transformative Celligent™ platform – a novel combination of robotics, imaging, and artificial intelligence that enables innovators to develop consistent, reproducible, and scalable GMP-compliant processes. Through this unique fusion of cutting-edge technologies, we have unlocked the ability to commercialize autologous and allogeneic cell therapies, as well as explore tissue engineering and artificial organ applications.
— Applications
Cell X is dedicated to advancing the promise of cellular therapies for innovators and patients alike. With the Celligent platform, we unlock the full potential of imaging, data analysis, and machine learning, enabling us to gain unprecedented insights into your cell culture processes needed to understand the transformation of stem cells into any cell in the body. The Celligent platform empowers early identification of outcome-based critical quality attributes, and helps determine replicable and reproducible critical process parameters. This comprehensive understanding of your cell processing workflow during the reprogramming, differentiation, and expansion processes lays the groundwork for the development of cell therapies with unmatched safety, facilitating consistent, reliable GMP manufacturing and regulatory compliance.
By harnessing the power of artificial intelligence, Celligent continually refines its processes, implementing Design of Experiments (DoE) studies to optimize each step of production. Moreover, a unique minable data structure allows us to gain invaluable insights into all parameters of your processes, ultimately making cell therapies more accessible to millions of patients worldwide.
The foundation of success lies in the critical beginning stages. We strongly emphasize ensuring your starting materials are optimized for success, safety, and efficacy by integrating automated controls to sharply reduce human error and contamination events. Our cutting-edge Celligent platform employs ‘BioAdaptive Automation™’, which means that weeding, picking, biopsying, media changing, and passaging are automated in response to biological cues such as confluency or colony size, thus adjusting to account for cells’ inherent variability.
With Celligent, you gain access to a comprehensive suite of features – from sample preparation to cell culturing and beyond – that ensure precise and reproducible results every time.
— Atraumatic picking & biopsying
— Imaging
— Positive & negative cell selection
Celligent's machine learning-driven platform is an evolving system that expands its capabilities with each new program. As Celligent processes cell colonies, it generates accurate and detailed annotations of each action and decision point, enabling researchers and scientists to gain deeper insights into their experiments. These annotations aid in current projects and form the foundation for expanding the platform's CxKnowledge data bank – a repository of information generated from past experiments and outcomes.
Celligent taps into the CxKnowledge data bank to guide researchers’ Design of Experiments approach for efficient and effective experiments that improve processes, while saving time and resources.
With each new project, Celligent's intelligent cell processing gets smarter.
— Integrated proprietary algorithms
— Automated annotation
— Ongoing functionality improvements
The Celligent platform's data collection and analytics integration is crucial to its success, streamlining the regulatory process and expediting IND filings through its ability to align cell processing with stringent regulatory standards. As Celligent operates, a wealth of invaluable data is gathered and stored in the CxKnowledge base. This comprehensive dataset is the bedrock for continuous advancements in Celligent's machine learning algorithm and is pivotal in establishing a program's proof of safety, efficacy, and reproducibility.
Celligent automatically measures, stores, and tracks everything your program needs for a successful IND filing.
— Physical data (Environmental Conditions and Procedural Data)
— Imaging data (Cell Proliferation Rate, Colony Analysis)
— Physiological and Molecular data (RNAseq, Flow panel, Karyotyping)
— 21 CFR Part 11 Compliant for GMP Operations
Cell X is revolutionizing cell processing. At the core of this revolution lies our transformative Celligent™ platform – a novel combination of robotics, imaging, and artificial intelligence that enables innovators to develop consistent, reproducible, and scalable GMP-compliant processes. Through this unique fusion of cutting-edge technologies, we have unlocked the ability to commercialize autologous and allogeneic cell therapies, as well as explore tissue engineering and artificial organ applications.
— Applications
Cell X is dedicated to advancing the promise of cellular therapies for innovators and patients alike. With the Celligent platform, we unlock the full potential of imaging, data analysis, and machine learning, enabling us to gain unprecedented insights into your cell culture processes needed to understand the transformation of stem cells into any cell in the body. The Celligent platform empowers early identification of outcome-based critical quality attributes, and helps determine replicable and reproducible critical process parameters. This comprehensive understanding of your cell processing workflow during the reprogramming, differentiation, and expansion processes lays the groundwork for the development of cell therapies with unmatched safety, facilitating consistent, reliable GMP manufacturing and regulatory compliance.
By harnessing the power of artificial intelligence, Celligent continually refines its processes, implementing Design of Experiments (DoE) studies to optimize each step of production. Moreover, a unique minable data structure allows us to gain invaluable insights into all parameters of your processes, ultimately making cell therapies more accessible to millions of patients worldwide.
The foundation of success lies in the critical beginning stages. We strongly emphasize ensuring your starting materials are optimized for success, safety, and efficacy by integrating automated controls to sharply reduce human error and contamination events. Our cutting-edge Celligent platform employs ‘BioAdaptive Automation™’, which means that weeding, picking, biopsying, media changing, and passaging are automated in response to biological cues such as confluency or colony size, thus adjusting to account for cells’ inherent variability.
With Celligent, you gain access to a comprehensive suite of features – from sample preparation to cell culturing and beyond – that ensure precise and reproducible results every time.
— Atraumatic picking & biopsying
— Imaging
— Positive & negative cell selection
Celligent's machine learning-driven platform is an evolving system that expands its capabilities with each new program. As Celligent processes cell colonies, it generates accurate and detailed annotations of each action and decision point, enabling researchers and scientists to gain deeper insights into their experiments. These annotations aid in current projects and form the foundation for expanding the platform's CxKnowledge data bank – a repository of information generated from past experiments and outcomes.
Celligent taps into the CxKnowledge data bank to guide researchers’ Design of Experiments approach for efficient and effective experiments that improve processes, while saving time and resources.
With each new project, Celligent's intelligent cell processing gets smarter.
— Integrated proprietary algorithms
— Automated annotation
— Ongoing functionality improvements
The Celligent platform's data collection and analytics integration is crucial to its success, streamlining the regulatory process and expediting IND filings through its ability to align cell processing with stringent regulatory standards. As Celligent operates, a wealth of invaluable data is gathered and stored in the CxKnowledge base. This comprehensive dataset is the bedrock for continuous advancements in Celligent's machine learning algorithm and is pivotal in establishing a program's proof of safety, efficacy, and reproducibility.
Celligent automatically measures, stores, and tracks everything your program needs for a successful IND filing.
— Physical data (Environmental Conditions and Procedural Data)
— Imaging data (Cell Proliferation Rate, Colony Analysis)
— Physiological and Molecular data (RNAseq, Flow panel, Karyotyping)
— 21 CFR Part 11 Compliant for GMP Operations
The Cell X team comprises industry veterans with diverse backgrounds in advanced therapies and industrial automation Our wealth of experience in cutting-edge technologies and groundbreaking research methodologies underscores our unwavering commitment to revolutionizing the life sciences industry. With a passion for pushing the boundaries, our team has been purpose-built to foster an environment of innovation.
